血管生成
内科学
内分泌学
细胞因子
细胞生物学
转基因
受体
生物
基因剔除小鼠
转录因子
生长因子
心力衰竭
心肌保护
医学
串扰
转基因小鼠
血管内皮生长因子A
心功能曲线
血管内皮生长因子
重组DNA
内皮干细胞
心脏发育
信号转导
基因靶向
表型
体内
激酶插入结构域受体
成纤维细胞生长因子
药理学
糖尿病
心肌梗塞
作者
Sanskruti Ravindra Gare,Nasser hawimel o Alatawi,Xinyi Chen,Jiayan Zhang,C. A. Ross,Oveena Fonseka,Yihua Han,Namrita Kaur,Andrea Ruiz‐Velasco,Xiangjun Zhao,Yingjuan Liu,Riham Abouleisa,Susanne S. Hille,Tao Wang,Sabu Abraham,Bernard D. Keavney,Martin K. Rutter,Elizabeth J. Cartwright,Gareth J. Howell,Tamer Mohamed
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2026-09-29
卷期号:139 (10): e327950-e327950
被引量:1
标识
DOI:10.1161/circresaha.125.327950
摘要
BACKGROUND: Endothelial defects in the heart are a contributor to cardiac pathological remodeling and dysfunction, which can be influenced by cardiomyocytes. Here, we explore cardioprotective crosstalk between cardiomyocytes and endothelial cells under diabetic conditions. METHODS: Type 2 diabetes was induced in male and female mice using a high-fat, high-sucrose diet in conjunction with low-dose streptozotocin. Cardiomyocyte-specific deletion of FGFR1 (fibroblast growth factor receptor 1) or KLB (beta-Klotho) was achieved by crossing floxed mice with αMHC (alpha-myosin heavy chain)-Cre transgenic mice, while the treatment potential was assessed by recombinant adeno-associated virus 9 delivery systems or administration of recombinant protein. Various in vitro models were used to investigate the mechanisms under a diabetes-like condition. The molecular mechanisms were explored through transcriptomics, proteomics, cytokine arrays, angiogenesis assays, histology, and luciferase reporter assays. RESULTS: Human diabetic hearts exhibited impaired angiogenic pathways with a marked reduction in myocardial capillary density. Multiomics profiling also revealed alterations in the FGFR1 (fibroblast growth factor receptor 1) pathway in mouse diabetic hearts. Both cardiomyocyte-specific FGFR1- and KLB- knockout mice exhibited reduced capillary abundance and developed decompensated cardiac remodeling. Mechanistic studies identified CEBPβ (CCAAT/enhancer binding protein beta) as a downstream transcription factor of the FGFR1/KLB pathway regulating MFG-E8 (milk fat globule-EGF factor 8) expression in cardiomyocytes. Cardiomyocyte-secreted MFG-E8 enhanced endothelial viability and branching. Importantly, the detrimental effects on the heart were rescued by corestoration of cardiac FGFR1 and KLB, whereas neither alone was sufficient, underscoring their synergistic action against diabetic stress. Finally, genetic or pharmacological enhancement of MFG-E8 reversed myocardial capillary rarefaction and led to an improvement in cardiac function, albeit with more pronounced therapeutic effects in males. CONCLUSIONS: Our findings demonstrate FGFR1/KLB-mediated cardioprotective mechanisms through cardiomyocyte-endothelial cell crosstalk and provide evidence that preserving adaptive remodeling represents a promising strategy to alleviate heart failure in both sexes.
科研通智能强力驱动
Strongly Powered by AbleSci AI